6.
Lozzio C, LOZZIO B
. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975; 45(3):321-34.
View
7.
Bony V, Gane P, Bailly P, Cartron J
. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol. 1999; 107(2):263-74.
DOI: 10.1046/j.1365-2141.1999.01721.x.
View
8.
Mouro I, Colin Y, Cherif-Zahar B, Cartron J, Le Van Kim C
. Molecular genetic basis of the human Rhesus blood group system. Nat Genet. 1993; 5(1):62-5.
DOI: 10.1038/ng0993-62.
View
9.
Tournamille C, Colin Y, Cartron J, Le Van Kim C
. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet. 1995; 10(2):224-8.
DOI: 10.1038/ng0695-224.
View
10.
Scully E, Shabani E, Rangel G, Gruring C, Kanjee U, Clark M
. Generation of an immortalized erythroid progenitor cell line from peripheral blood: A model system for the functional analysis of Plasmodium spp. invasion. Am J Hematol. 2019; 94(9):963-974.
PMC: 6984401.
DOI: 10.1002/ajh.25543.
View
11.
Sprussel A, Schulte J, Weber S, Necke M, Handschke K, Thor T
. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia. 2012; 26(9):2039-51.
DOI: 10.1038/leu.2012.157.
View
12.
Cherif-Zahar B, Le Van Kim C, ROUILLAC C, Raynal V, Cartron J, Colin Y
. Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region. Genomics. 1994; 19(1):68-74.
DOI: 10.1006/geno.1994.1014.
View
13.
Li J, Hale J, Bhagia P, Xue F, Chen L, Jaffray J
. Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood. 2014; 124(24):3636-45.
PMC: 4256913.
DOI: 10.1182/blood-2014-07-588806.
View
14.
Fares I, Chagraoui J, Lehnertz B, MacRae T, Mayotte N, Tomellini E
. EPCR expression marks UM171-expanded CD34 cord blood stem cells. Blood. 2017; 129(25):3344-3351.
DOI: 10.1182/blood-2016-11-750729.
View
15.
Nandakumar S, Ulirsch J, Sankaran V
. Advances in understanding erythropoiesis: evolving perspectives. Br J Haematol. 2016; 173(2):206-18.
PMC: 4833665.
DOI: 10.1111/bjh.13938.
View
16.
Picaud S, da Costa D, Thanasopoulou A, Filippakopoulos P, Fish P, Philpott M
. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains. Cancer Res. 2013; 73(11):3336-46.
PMC: 3673830.
DOI: 10.1158/0008-5472.CAN-12-3292.
View
17.
Chaudhuri A, Zbrzezna V, Polyakova J, Pogo A, Hesselgesser J, Horuk R
. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J Biol Chem. 1994; 269(11):7835-8.
View
18.
Kanjee U, Gruring C, Chaand M, Lin K, Egan E, Manzo J
. CRISPR/Cas9 knockouts reveal genetic interaction between strain-transcendent erythrocyte determinants of invasion. Proc Natl Acad Sci U S A. 2017; 114(44):E9356-E9365.
PMC: 5676921.
DOI: 10.1073/pnas.1711310114.
View
19.
Altenburg B, Frings M, Schobel J, Gossen J, Pannen K, Vanderliek K
. Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid Malignancies. ACS Med Chem Lett. 2020; 11(10):1928-1934.
PMC: 7549261.
DOI: 10.1021/acsmedchemlett.9b00625.
View
20.
Li Y, Zhang Q, Yin X, Yang W, Du Y, Hou P
. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res. 2010; 21(1):196-204.
PMC: 3193405.
DOI: 10.1038/cr.2010.142.
View